Comparison of 25-hydroxy vitamin D serum levels among children with epilepsy in therapy with single versus multiple antiseizure medications
© 2023 The Authors. Published by Elsevier Inc..
Objective: Treatment with antiseizure medications (ASMs) for more than 6 months requires monitoring of side effects, one of which is a decreased level of serum vitamin D. This study aimed to compare the influence of therapies with one versus multiple ASMs on 25-hydroxy vitamin D (25-OHD) levels among children with epilepsy.
Methods: Our cross-sectional comparative study was conducted in the Paediatric Neurology Clinic at Soetomo Academic Hospital. Epileptic children aged 2-18 years who had been using ASMs for at least 6 months were enrolled and grouped according to whether they had been taking single or multiple ASMs. The mean 25-OHD levels of both groups were compared using a Welch t-test (95% confidence interval).
Results: Among the 60 children enrolled, vitamin D deficiency was identified in 13% of children taking a single ASM and in 53% of ones taking multiple ASMs; mean 25-OHD levels were 26.6 (SD 5.29) ng/mL and 20.2 (SD 4.25) ng/mL, respectively. There was a significant difference between the groups (p = 0.001).
Conclusions: Patients taking single and multiple ASMs have lower 25-OHD levels than expected for their age, with those taking multiple ASMs having the lowest 25-OHD levels.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Epilepsy & behavior reports - 24(2023) vom: 30., Seite 100620 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Indra Gunawan, Prastiya [VerfasserIn] |
---|
Links: |
---|
Themen: |
25-Hydroxy vitamin D |
---|
Anmerkungen: |
Date Revised 09.09.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.ebr.2023.100620 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361783345 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361783345 | ||
003 | DE-627 | ||
005 | 20231226085852.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ebr.2023.100620 |2 doi | |
028 | 5 | 2 | |a pubmed24n1205.xml |
035 | |a (DE-627)NLM361783345 | ||
035 | |a (NLM)37680766 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Indra Gunawan, Prastiya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparison of 25-hydroxy vitamin D serum levels among children with epilepsy in therapy with single versus multiple antiseizure medications |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 09.09.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 The Authors. Published by Elsevier Inc. | ||
520 | |a Objective: Treatment with antiseizure medications (ASMs) for more than 6 months requires monitoring of side effects, one of which is a decreased level of serum vitamin D. This study aimed to compare the influence of therapies with one versus multiple ASMs on 25-hydroxy vitamin D (25-OHD) levels among children with epilepsy | ||
520 | |a Methods: Our cross-sectional comparative study was conducted in the Paediatric Neurology Clinic at Soetomo Academic Hospital. Epileptic children aged 2-18 years who had been using ASMs for at least 6 months were enrolled and grouped according to whether they had been taking single or multiple ASMs. The mean 25-OHD levels of both groups were compared using a Welch t-test (95% confidence interval) | ||
520 | |a Results: Among the 60 children enrolled, vitamin D deficiency was identified in 13% of children taking a single ASM and in 53% of ones taking multiple ASMs; mean 25-OHD levels were 26.6 (SD 5.29) ng/mL and 20.2 (SD 4.25) ng/mL, respectively. There was a significant difference between the groups (p = 0.001) | ||
520 | |a Conclusions: Patients taking single and multiple ASMs have lower 25-OHD levels than expected for their age, with those taking multiple ASMs having the lowest 25-OHD levels | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a 25-Hydroxy vitamin D | |
650 | 4 | |a Antiseizure medication | |
650 | 4 | |a Disease | |
650 | 4 | |a Epilepsy | |
700 | 1 | |a Rochmah, Nur |e verfasserin |4 aut | |
700 | 1 | |a Faizi, Muhammad |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Epilepsy & behavior reports |d 2019 |g 24(2023) vom: 30., Seite 100620 |w (DE-627)NLM299583546 |x 2589-9864 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2023 |g day:30 |g pages:100620 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ebr.2023.100620 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2023 |b 30 |h 100620 |